arrow
Back
T

Thomas J. Kipps

Moores Cancer Center

120H-index
1.0KPaper Count
6.3WCitation Count
Published Papers 191
Publication Date
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway
err2025-09-09
err0
errOAAI
errZhang, Bo; Iyer, Prajish; Jin, Meiling; Ten Hacken, Elisa; Cartun, Zachary J.; Hart, Kevyn L.; Fernandez, Mike; Stevenson, Kristen; Rassenti, Laura; Ghia, Emanuela M.; Kipps, Thomas J.; Neuberg, Donna; Carrasco, Ruben; Chan, Wing C.; Song, Joo Y.; Hu, Yu; Wu, Catherine J.; Wang, Lili
errShare
errSave
Targeting PRDX1 impairs acute myeloid leukemic blasts and stem cells by disrupting redox homeostasis
err2025-08-18
err0
errOAAI
errZhenghao Li; Guangci Liu; Ziren Chen; Keming Li; Zhe Yu; Chao He; Xinyu Ying; Danling Huang; Chengtian Tao; Sajid Khan; Yimeng Wang; Fang-Lin Zhang; Huan Li; Yun Chen; Jingfeng Zhou; Li Yu; Thomas J. Kipps; Yongxian Cheng; Suping Zhang
errShare
errSave
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL
errBlood
IF23.1
err2025-08-05
err0
errOAAI
errJan A. Burger; Paul M. Barr; Tadeusz Robak; Carolyn Owen; Alessandra Tedeschi; Anita Sarma; Piers E. M. Patten; Sebastian Grosicki; Helen McCarthy; Fritz Offner; Edith Szafer-Glusman; Cathy Zhou; Anita Szoke; Lynne Neumayr; James P. Dean; Paolo Ghia; Thomas J. Kipps
errShare
errSave
Wnt5a induces ROR1 dependent NF-κB activation to enhance MMP-9 expression and invasiveness in chronic lymphocytic leukemia
errLEUKEMIA
IF13.4
err2025-04-28
err0
errOAAI
errHasan, Md Kamrul; Widhopf II, George F.; Ghia, Emanuela M.; Kipps, Thomas J.
errShare
errSave
Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma
err2025-01-01
err0
errOAAI
errLeng, Feng; Huang, Jiajia; Wu, Liufeng; Zhang, Jianchao; Lin, Xinxin; Deng, Ruhuan; Zhu, Jinhang; Li, Zhen; Li, Zhenghao; Wang, Yimeng; Zhang, Han; Lu, Desheng; Kipps, Thomas J.; Zhang, Suping
errShare
errSave
Expression of ROR1 and ROR2 in Hairy Cell Leukemia Cells Enhances Constitutive Activation of ERK1/2 and Cancer Stemness
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errWidhopf II, George F.; Ghia, Emanuela M.; Cring, Matthew R.; Kipps, Thomas J.
errShare
errSave
Comparative Analysis of Patient Characteristics, Treatment Modalities, and Survival Outcomes in Chronic Lymphocytic Leukemia from China and the US
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errYan, Yuting; Liu, Yin; Yang, Fan; Liu, Jiamei; Chen, Yanfei; Yu, Ying; Wenjie, Xiong; Wang, Tingyu; Xiao, Zhijian; Wang, Jianxiang; Kipps, Thomas J.; Gale, Robert Peter; Qiu, Lu-Gui; Zhou, Jifang; Yi, Shuhua
errShare
errSave
Wnt5a Enhances Chemokine-Directed Migration of T-Cells Made to Express ROR1
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errElson, Daniel; Oh, Christopher Seungwhan; Cring, Matthew R.; Widhopf Ii, George F.; Kipps, Thomas J.
errShare
errSave
Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemia
errLEUKEMIA
IF13.4
err2024-07-24
err4
errOAAI
errWong, Richard L.; Choi, Michael Y.; Wang, Huan-You; Kipps, Thomas J.
errShare
errSave
Variant Transcript of ROR1 ENST00000545203 Does Not Encode ROR1 Protein
err2024-07-16
err0
errOAAI
errXian, Jie; Sinha, Navyaa; Girgis, Christina; Oh, Christopher S.; Cring, Matthew R.; Widhopf II, George F.; Kipps, Thomas J.
errShare
errSave
Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2024
err2024-04-01
err1
errOAAI
errWierda, William G.; Brown, Jennifer; Abramson, Jeremy S.; Awan, Farrukh; Bilgrami, Syed F.; Bociek, Greg; Brander, Danielle; Cortese, Matthew; Cripe, Larry; Davis, Randall S.; Eradat, Herbert; Fakhri, Bita; Fletcher, Christopher D.; Gaballa, Sameh; Hamid, Muhammad Saad; Hill, Brian; Kaesberg, Paul; Kahl, Brad; Kamdar, Manali; Kipps, Thomas J.; Ma, Shuo; Mosse, Claudio; Nakhoda, Shazia; Parikh, Sameer; Schorr, Andrew; Schuster, Stephen; Seshadri, Madhav; Siddiqi, Tanya; Stephens, Deborah M.; Thompson, Meghan; Ujjani, Chaitra; Valdez, Riccardo; Wagner-Johnston, Nina; Woyach, Jennifer A.; Sundar, Hema; Dwyer, Mary
errShare
errSave
a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer (vol 26, 32, 2024)
err2024-03-13
err2
errOAAI
errShatsky, Rebecca A.; Batra-Sharma, Hemali; Helsten, Teresa; Schwab, Richard B.; Pittman, Emily I.; Pu, Minya; Weihe, Elizabeth; Ghia, Emanuela M.; Rassenti, Laura Z.; Molinolo, Alfredo; Cabrera, Betty; Breitmeyer, James B.; Widhopf II, George F.; Messer, Karen; Jamieson, Catriona; Kipps, Thomas J.; Parker, Barbara A.
errShare
errSave
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer
err2024-02-26
err3
errOAAI
errShatsky, Rebecca A.; Batra-Sharma, Hemali; Helsten, Teresa; Schwab, Richard B.; Pittman, Emily I.; Pu, Minya; Weihe, Elizabeth; Ghia, Emanuela M.; Rassenti, Laura Z.; Molinolo, Alfredo; Cabrera, Betty; Breitmeyer, James B.; Widhopf II, George F.; Messer, Karen; Jamieson, Catriona; Kipps, Thomas J.; Parker, Barbara A.
errShare
errSave
Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia
err2023-10-23
err2
errOAAI
errLa Ferlita, Alessandro; Nigita, Giovanni; Tsyba, Liudmyla; Palamarchuk, Alexey; Alaimo, Salvatore; Pulvirenti, Alfredo; Balatti, Veronica; Rassenti, Laura; Tsichlis, Philip N.; Kipps, Thomas; Pekarsky, Yuri; Croce, Carlo M.
errShare
errSave
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study
err2023-09-14
err8
errOAAI
errMoreno, Carol; Solman, Isabelle G.; Tam, Constantine S.; Grigg, Andrew; Scarfo, Lydia; Kipps, Thomas J.; Srinivasan, Srimathi; Mali, Raghuveer Singh; Zhou, Cathy; Dean, James P.; Szafer-Glusman, Edith; Choi, Michael
errShare
errSave
Assessing clinical and pharmacodynamic (PD) profiles of patients (pts) with chronic lymphocytic leukemia (CLL) on ianalumab (VAY736) + ibrutinib
err2023-04-14
err0
errOAAI
errRogers, Kerry Anne; Yan, Pearlly; Flinn, Ian W.; Stephens, Deborah M.; Kipps, Thomas J.; Larson, Sarah M.; Martz, Laura; Chen, Xi; Wang, Huabao; Hopping, Ethan; Bundschuh, Ralf; Acosta, Alexandra; Baldoni, Daniela; Chaudhury, Anwesha; Whalen, Jeanne; Hassounah, Nadia B.; Orwitz, Nina; Woo, Janghee; Byrd, John C.
errShare
errSave
Similar outcomes regardless of post-randomization treatment with ibrutinib or ibrutinib plus venetoclax in the phase 2 CAPTIVATE study of first-line ibrutinib plus venetoclax in CLL
err2023-04-14
err0
PREAI
errSiddiqi, Tanya; Tam, Constantine S.; Wierda, William G.; Ghia, Paolo; Kipps, Thomas J.; Tedeschi, Alessandra; Gonzalez-Barca, Eva; Szafer-Glusman, Edith; Zhou, Cathy; Neumayr, Lynne D.; Allan, John N.
errShare
errSave
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial
err2023-04-08
err6
errOAAI
errParker, Barbara A.; Shatsky, Rebecca A.; Schwab, Richard B.; Wallace, Anne M.; Wolf, Denise M.; Hirst, Gillian L.; Brown-Swigart, Lamorna; Esserman, Laura J.; van 't Veer, Laura J.; Ghia, Emanuela M.; Yau, Christina; Kipps, Thomas J.
errShare
errSave
Pre- clinical studies to advance anti-ROR1 CAR-T cell therapy for metastatic prostate cancer
err2023-04-04
err0
PREAI
errJamieson, Christina A. M.; Murtadha, Jamillah; Oh, Christopher S.; Muldong, Michelle; Koutouan, Evodie; Kim, JOngwook; Etemadfard, Niloofar; Choo, Hae Soo; Sinha, Navyaa; Lee, Sanghee; Wu, Christina; Pineda, Gabriel; Lennon, Kathleen; Willert, Karl; Jamieson, Catriona H.; Gaasterland, Terry; Mckay, Rana; Kane, Christopher J.; Kipps, Thomas J.; Kulidjian, Anna A.; Cacalano, Nicholas A.; Prussak, Charles
errShare
errSave